FDA Wants Another "Black Box" Warning For Avandia
Amid growing concerns over the safety of Avandia, the U.S. Food and Drug Administration is reportedly pushing for the diabetes drug's manufacturer GlaxoSmithKline PLC to add an additional so-called "black box"...To view the full article, register now.
Already a subscriber? Click here to view full article